<- Go Home
Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Market Cap
CHF 42.1B
Volume
767.4K
Cash and Equivalents
CHF 1.7B
EBITDA
CHF 2.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CHF 5.5B
Profit Margin
55.65%
52 Week High
CHF 101.62
52 Week Low
CHF 82.82
Dividend
0.38%
Price / Book Value
1.95
Price / Earnings
41.49
Price / Tangible Book Value
10.47
Enterprise Value
CHF 45.4B
Enterprise Value / EBITDA
17.61
Operating Income
CHF 1.4B
Return on Equity
4.83%
Return on Assets
2.85
Cash and Short Term Investments
CHF 1.8B
Debt
CHF 5.1B
Equity
CHF 21.6B
Revenue
CHF 9.9B
Unlevered FCF
CHF 1.5B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium